-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of long-term debt and lease obligation, classified as noncurrent.
-
Summary
-
Recursion Pharmaceuticals, Inc. quarterly Long-term Debt and Lease Obligation history and growth rate from Q4 2023 to Q4 2024.
- Recursion Pharmaceuticals, Inc. Long-term Debt and Lease Obligation for the quarter ending December 31, 2024 was $19M, a 1628% increase year-over-year.
Long-term Debt and Lease Obligation, Quarterly (USD)
Long-term Debt and Lease Obligation, YoY Quarterly Growth (%)